Literature DB >> 23733357

Neuropeptide Y modulates fracture healing through Y1 receptor signaling.

Daniela M Sousa1, Michelle M McDonald, Kathy Mikulec, Lauren Peacock, Herbert Herzog, Meriem Lamghari, David G Little, Paul A Baldock.   

Abstract

Neuropeptide Y acting via it's Y1 receptor represents a powerful pathway in the control of bone mass. The global or osteoblast-specific Y1 receptor deletion induces pronounced bone anabolic effects in mice. However, the contribution of Y1 receptor deletion in bone repair/healing remained to be clarified. Therefore, in this study we characterized the role of Y1 receptor deletion in fracture healing. Closed tibial fractures were generated in germline (Y1 (-/-) ) and osteoblastic-specific Y1 receptor knockout mice. The progression of tibial repair monitored from 1- until 6-weeks post-fracture demonstrated that in Y1 (-/-) mice there is a delay in fracture repair, as seen by a decrease in bone callus volume and callus strength. Moreover, the histological features included elevated avascular and cartilage area and consequently delayed cartilage removal, and hence impaired union. Interestingly, this delay in bone repair was not related directly to Y1 receptors expressed by mature osteoblasts. These findings suggest that the global absence of the Y1 receptor delays fracture healing, through impairing the early phases of fracture repair to achieve bony union. The data acquired on the role of Y1 receptor signaling disruption in bone regeneration is critical for the design of future therapeutic strategies.
Copyright © 2013 Orthopaedic Research Society.

Entities:  

Keywords:  Y1 receptor; bone; fracture healing; nervous system; neuropeptide Y

Mesh:

Substances:

Year:  2013        PMID: 23733357     DOI: 10.1002/jor.22400

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  11 in total

Review 1.  Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis.

Authors:  Harry Horsnell; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

2.  Neuropeptide Y mediates glucocorticoid-induced osteoporosis and marrow adiposity in mice.

Authors:  F-S Wang; W-S Lian; W-T Weng; Y-C Sun; H-J Ke; Y-S Chen; J-Y Ko
Journal:  Osteoporos Int       Date:  2016-04-14       Impact factor: 4.507

3.  [Neuropeptide Y Y1 receptor antagonist PD160170 promotes osteogenic differentiation of rat bone marrow mesenchymal stem cells in vitro and femoral defect repair in rats].

Authors:  Song Liu; Jian-Qun Wu; Ji-Jie Hu; Le Wang; Zhao Wang; Huan Meng; Ling-Jian Zhuo; Jian-Xiong Zheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-06-20

4.  Neuropeptide Y, substance P, and human bone morphogenetic protein 2 stimulate human osteoblast osteogenic activity by enhancing gap junction intercellular communication.

Authors:  W H Ma; Y J Liu; W Wang; Y Z Zhang
Journal:  Braz J Med Biol Res       Date:  2015-02-13       Impact factor: 2.590

5.  Bone Injury and Repair Trigger Central and Peripheral NPY Neuronal Pathways.

Authors:  Cecília J Alves; Inês S Alencastre; Estrela Neto; João Ribas; Sofia Ferreira; Daniel M Vasconcelos; Daniela M Sousa; Teresa Summavielle; Meriem Lamghari
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

6.  Ablation of Y1 receptor impairs osteoclast bone-resorbing activity.

Authors:  Daniela M Sousa; Francisco Conceição; Diana I Silva; Luís Leitão; Estrela Neto; Cecília J Alves; Inês S Alencastre; Herbert Herzog; Paulo Aguiar; Meriem Lamghari
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

Review 7.  The role of GPCRs in bone diseases and dysfunctions.

Authors:  Jian Luo; Peng Sun; Stefan Siwko; Mingyao Liu; Jianru Xiao
Journal:  Bone Res       Date:  2019-07-08       Impact factor: 13.567

Review 8.  Update on the Role of Neuropeptide Y and Other Related Factors in Breast Cancer and Osteoporosis.

Authors:  Shu-Ting Lin; Yi-Zhong Li; Xiao-Qi Sun; Qian-Qian Chen; Shun-Fa Huang; Shu Lin; Si-Qing Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-06       Impact factor: 5.555

Review 9.  Do Neuroendocrine Peptides and Their Receptors Qualify as Novel Therapeutic Targets in Osteoarthritis?

Authors:  Susanne Grässel; Dominique Muschter
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

10.  Effects of Early Life Stress on Bone Homeostasis in Mice and Humans.

Authors:  Karin Wuertz-Kozak; Martin Roszkowski; Elena Cambria; Andrea Block; Gisela A Kuhn; Thea Abele; Wolfgang Hitzl; David Drießlein; Ralph Müller; Michael A Rapp; Isabelle M Mansuy; Eva M J Peters; Pia M Wippert
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.